Full-Time

Quality Assurance Validation Engineer

Confirmed live in the last 24 hours

Serán BioScience

Serán BioScience

51-200 employees

Contract development and manufacturing for pharmaceuticals

No salary listed

Mid, Senior

No H1B Sponsorship

Bend, OR, USA

The job is onsite, requiring consistent and predictable in-person attendance.

Category
QA & Testing
Quality Assurance
Requirements
  • Understanding of current regulations and guidelines (e.g., 21 CFR Parts 11, 210, and 211, EudraLex Volume 4 - Annex 15, GAMP 5, etc.) and how to apply them to support the validation effort
  • Technical writing skills to effectively develop procedures, discrepancies, change controls, CAPAs and associated documents needed to support the validation effort
  • Hands-on experience with the qualification of facilities, utilities, equipment and/or computerized systems, cleaning or process validation (Experience in at least two of these areas is required)
  • Ability to manage multiple projects, create and work within internal timeliness, solve problems, deliver on commitments, and utilize interpersonal skills in a cross-functional team
  • Strong time-management skills and the ability to organize and coordinate multiple projects at a time
  • Communicates effectively and maintains productive relationships with coworkers, clients, and other contacts outside the Company
  • Ability to prioritize tasks and to keep leadership apprised of performance to timelines
  • Accepts feedback from a variety of sources and constructively manages conflict
Responsibilities
  • Generates and/or supports the generation of risk assessments, user requirements specifications (URS), C&Q plans, change controls, SOPs, CAPAs, and other relevant documents
  • Supports validation lifecycle activities such as, but not limited to, change management, periodic reviews, and re-qualification to ensure that qualified systems remain in their validated state
  • Makes compliance decisions to support clinical and commercial operations
  • Mentors colleagues on the reasons or justifications of the requirements and practices
  • Drives process improvement initiatives
  • Provides support during clients and regulatory audits
  • Performs other related duties as assigned
  • Responsibilities may increase in scope to align with company initiatives
Desired Qualifications
  • Experience in Oral Solid Dose operations and spray drying is preferable

Serán BioScience specializes in providing drug development and manufacturing services as a Contract Development and Manufacturing Organization (CDMO). They offer a variety of services, including preformulation, formulation development, dosage form development, spray drying, and particle engineering. Their operations adhere to current Good Manufacturing Practice (cGMP) standards, ensuring high quality and safety in their products through rigorous analytical quality control. Serán BioScience serves a wide range of clients, from small biotech startups to large pharmaceutical companies, by tailoring their services to meet specific client needs. This flexibility and dedication set them apart from competitors in the pharmaceutical and biotechnology markets. The company's goal is to enhance the efficiency and effectiveness of drug development processes for their clients.

Company Size

51-200

Company Stage

Growth Equity (Venture Capital)

Total Funding

$200M

Headquarters

Bend, Oregon

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Serán announced a $200 million strategic growth transaction for expansion.
  • The company plans to build a new commercial-scale manufacturing facility.
  • Increased demand for personalized medicine aligns with Serán's formulation expertise.

What critics are saying

  • Emerging CDMOs in Asia offer lower-cost services, impacting Serán's market share.
  • Potential delays in new facility construction could affect expansion plans.
  • Global talent shortage may hinder recruitment for Serán's expansion.

What makes Serán BioScience unique

  • Serán specializes in advanced drug formulation techniques, including spray drying and particle engineering.
  • The company offers cGMP manufacturing and analytical quality control services.
  • Serán's flexibility allows tailored services to meet specific client needs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

Health Insurance

Life Insurance

Disability Insurance

Mental Health Support

Pet Insurance

Growth & Insights and Company News

Headcount

6 month growth

15%

1 year growth

17%

2 year growth

17%
Bain Capital
Nov 18th, 2024
Serán Bioscience Announces $200 Million Strategic Growth Transaction and Plans for New Commercial Facility

Serán Bioscience announces $200 million strategic growth transaction and plans for new commercial facility.

TechMub
Sep 17th, 2024
Serán Bioscience Raises $200M for Strategic Expansion and New Commercial Facility

With over 200 team members, including 150 scientists and engineers, Serán plans to add 150 more employees as part of its expansion.

Contract Pharma
Sep 17th, 2024
Serán Bioscience Plans New Commercial-Scale Manufacturing Facility

Serán Bioscience, a contract development and manufacturing organization (CDMO) providing a comprehensive suite of development, analytical, and manufacturing services to pharmaceutical and biotechnology companies, has announced a strategic growth transaction of more than $200 million, which will support Serán's continued growth and construction of a new commercial-scale manufacturing facility.

BioSpace
Feb 7th, 2024
The Ira: A Catalyst For Societal Change

"Politics, Patients, and Pharma" Image Credit: Nicole Bean for BioSpaceWhen prescription drug benefits were added to Medicare via the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, the government was not given the ability to negotiate drug pricing. As a result, pharmaceutical companies were, and are, able to determine their own pricing. Another result is that prices for prescription drugs are higher in the U.S., significantly higher, than in most other developed countries.In a 2021 study conducted by the RAND Corporation, researchers estimated that U.S. drug prices were an average 2.56 times higher than the other 32 countries in the Organization for Economic Co-operation and Development (OECD). The gap increases to 3.44 times higher for larger brand-name drugs.Balancing Innovation, Pricing PatientsBoth the government and the pharma industry seek to give patients access to medications that enhance their quality of life. The question is how to achieve this without putting financial burdens on these patients

Cascade Business News
Nov 9th, 2023
Serán Bioscience Breaks Ground on Additional cGMP Manufacturing Capacity at its Bend Site

Serán is partnering with Oregon Bioscience Association ( oregonbio.org ) to establish a state-sponsored apprenticeship program with the goal of providing paid employment and education to entry-level operations and laboratory technicians.